Internal Server Error

List of ANI Pharmaceuticals's Acquisitions

lockFilter this list
ANI Pharmaceuticals has made a total of 5 acquisitions. These investments span 3 sectors: Pharmaceutical Distributors, Biopharma Outsourcing, and Ophthalmology. All 1 country involved is United States. Activity peaked in 2024, 2021, and 2018, with 1 acquisition each. Between 2020 and 2025, the average is 0.4 acquisitions per year, with 0 acquisitions completed in the current calendar year. The most recent acquisition is Alimera Sciences, an Alpharetta-based developer of therapeutic solutions for diabetic macular edema (DME) founded in 2003, which was acquired in July 2024.

Here's the year on year acquisition history of ANI Pharmaceuticals:

Year on year acquisition history of ANI Pharmaceuticals2024202120182017Acquisitions Round Date (Yearly)012
  • Number of Total Acquisitions
Year
# Acquisitions
2024
1
2021
1
2018
1
2017
1
2016
1

Recent acquisitions by ANI Pharmaceuticals

ANI Pharmaceuticals's most recent acquisition - Alimera Sciences is a Developer of therapeutic solutions to treat diabetic macular edema (DME), founded in 2003 and located in Alpharetta. ANI Pharmaceuticals acquired it in July 2024 for a price of $*****.

Here is the list of all acquisitions by ANI Pharmaceuticals sorted by the latest acquisition date:

Acquired on
Acquired Company
Acquisition Price
Facilitators
Stake Acquired
Acquisition Multiple
Jul 17, 2024
icel
lutp
64
585
Mar 09, 2021
ksxd
cmbf
12
786
Aug 06, 2018
luwy
yash
26
984

View the full list of acquisitions

Sign Up for Free

FAQs about Acquisitions by ANI Pharmaceuticals

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford